|
|
||||||||
Original Article |
BACKGROUND: The c-myc proto-oncogene has been suggested to play key roles in cell proliferation, differentiation, transformation and apoptosis. A variety of functions of C-MYC, the product of c-myc, are attributed to protein-protein interactions with various cellular factors including Max, YY1, p107, Bin1 and TBP. Max and YY1 bind to the C-terminal region of C-MYC, while p107, Bin1 and TBP bind to the N-terminal region covering myc boxes. The N-terminal region is involved in all the biological functions of C-MYC, and different proteins are therefore thought to interact with the N-terminal region of C-MYC to display different functions. RESULTS: We cloned two cDNAs which encode a novel C-MYC-binding protein of 11 kDa, designated AMY-1 (Associate of C-MYC). The two cDNAs, AMY-1L and AMY-1S, derived from alternative usage of polyadenylation signals, code for the same protein of 11 kDa. AMY-1 was bound via its C-terminal region to the N-terminal region of C-MYC (amino acids nos 58-148) corresponding to the transactivation domain. AMY-1 was localized in the cytoplasm in cells expressing c-myc at low levels, but in the nucleus in the cells of a high c-myc expression in transiently transfected cells. A similar difference in endogenous AMY-1 localization was observed during the cell cycle: AMY-1 translocated from cytoplasm to nucleus during the S phase when c-myc expression was increased. AMY-1 by itself did not recognize the E-box element, the MYC/Max binding sequence, nor did it transactivate via the element, but stimulated the activation of E-box-regulated transcription by MYC/Max. FISH analyses revealed that the amy-1 gene was located at 1p32.2-1p33 in human genome. CONCLUSIONS: AMY-1 is a 11 kDa protein which binds to the N-terminal region of C-MYC and stimulates the activation of E-box-dependent transcription by C-MYC. AMY-1, which mostly localizes in the cytoplasm, translocates into the nucleus in the S phase of the cell cycle upon an increase of c-myc expression, and may thus control the transcriptional activity of C-MYC.
This article has been cited by other articles:
![]() |
M. Shibuya, H. Okamoto, T. Nozawa, J. Utsumi, V. N. Reddy, H. Echizen, Y. Tanaka, and T. Iwata Proteomic and Transcriptomic Analyses of Retinal Pigment Epithelial Cells Exposed to REF-1/TFPI-2 Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 516 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ishizaki, H.-W. Shin, S. M. M. Iguchi-Ariga, H. Ariga, and K. Nakayama AMY-1 (associate of Myc-1) localization to the trans-Golgi network through interacting with BIG2, a guanine-nucleotide exchange factor for ADP-ribosylation factors. Genes Cells, August 1, 2006; 11(8): 949 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Doorn, R. Dijkman, M. H. Vermeer, J. J. Out-Luiting, E. M. H. van der Raaij-Helmer, R. Willemze, and C. P. Tensen Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sezary Syndrome Identified by Gene Expression Analysis Cancer Res., August 15, 2004; 64(16): 5578 - 5586. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Semizarov, P. Kroeger, and S. Fesik siRNA-mediated gene silencing: a global genome view Nucleic Acids Res., July 22, 2004; 32(13): 3836 - 3845. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xiao, P. Jethanandani, B. L. Ziober, and R. H. Kramer Regulation of {alpha}7 Integrin Expression during Muscle Differentiation J. Biol. Chem., December 12, 2003; 278(50): 49780 - 49788. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takahashi, F. Higashino, M. Aoyagi, K. Yoshida, M. Itoh, S. Kyo, T. Ohno, T. Taira, H. Ariga, K. Nakajima, et al. EWS/ETS Fusions Activate Telomerase in Ewing's Tumors Cancer Res., December 1, 2003; 63(23): 8338 - 8344. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Flinn, A. E. Wallberg, S. Hermann, P. A. Grant, J. L. Workman, and A. P. H. Wright Recruitment of Gcn5-containing Complexes during c-Myc-dependent Gene Activation. STRUCTURE AND FUNCTION ASPECTS J. Biol. Chem., June 21, 2002; 277(26): 23399 - 23406. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kitaura, M. Shinshi, Y. Uchikoshi, T. Ono, T. Tsurimoto, H. Yoshikawa, S. M. M. Iguchi-Ariga, and H. Ariga Reciprocal Regulation via Protein-Protein Interaction between c-Myc and p21cip1/waf1/sdi1 in DNA Replication and Transcription J. Biol. Chem., March 31, 2000; 275(14): 10477 - 10483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kyo, M. Takakura, T. Taira, T. Kanaya, H. Itoh, M. Yutsudo, H. Ariga, and M. Inoue Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) Nucleic Acids Res., February 1, 2000; 28(3): 669 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taira, M. Sawai, M. Ikeda, K. Tamai, S. M. M. Iguchi-Ariga, and H. Ariga Cell Cycle-dependent Switch of Up- and Down-regulation of Human hsp70 Gene Expression by Interaction between c-Myc and CBF/NF-Y J. Biol. Chem., August 20, 1999; 274(34): 24270 - 24279. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujioka, T. Taira, Y. Maeda, S. Tanaka, H. Nishihara, S. M. M. Iguchi-Ariga, K. Nagashima, and H. Ariga MM-1, a c-Myc-binding Protein, Is a Candidate for a Tumor Suppressor in Leukemia/Lymphoma and Tongue Cancer J. Biol. Chem., November 21, 2001; 276(48): 45137 - 45144. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |